Products & Product Pipeline

Cinnergen is a liquid whole food supplement that provides vital nutrients essential for metabolizing and normalizing blood sugar. Cinnergen has been clinically proven in a double blind placebo controlled study to decrease the symptoms commonly associated with elevated blood sugar. Over half of the participants were able to eliminate their need for oral diabetic medications within 90 days.

Learn more: www.cinnergen.com

Talsyn CI/bid is a topical cream used for the management of keloids (raised, reddish scars that develop at the site of an injury), hypertrophic scars (a more common scar similar to keloids), erythema multiforme (a skin disorder resulting from an allergic reaction), and surgical incisions. Talsyn-CI has been clinically shown to improve both the appearance and condition of existing scars.

Formulated entirely of food grade products, eFoodSafety.com’s Anthrax Sporicidal is an environmentally safe sporicide that eradicates the Environmental Protection Agency’s (EPA) designated surrogate for Anthrax, Bacillus Subtilis. It has been proven to provide 100% efficacy against both Clostridium Sporogenes and Bacillus Subtillis on both hard and porous surfaces.

With at least 200 million acute cases of malaria occurring worldwide every year, safe, effective treatments are in high demand. To that end, Auromoxin’s proprietary formula is currently undergoing testing on live tissue samples inoculated with malaria (Plasmodium Falciparum) at the National Center for Genetic Engineering and Biotechnology (BIOTEC), a branch of the National Science and Technology Department Agency, located in Bangkok, Thailand. Initial results have been very promising.

Cinnechol is a multi-faceted all natural nutritional supplement designed to reduce total cholesterol levels, LDL (“bad”) cholesterol, and triglycerides without adverse side effects. It has also been shown to improve levels of HDL (“good”) cholesterol. Cinnechol’s all natural ingredients work synergistically to decrease the viscosity, or thickness of the blood, allowing for better circulation, and assist in fighting inflammation which is vital to the health of the heart and blood vessels.

Citroxin is an environmentally safe product formulated entirely of food-grade components. In Environmental Protection Agency (EPA) required laboratory tests, Citroxin showed a 100% kill rate for the “big six” bacterial health threats as follows: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza and Black Mold.

Citroxin O2 is a fully ingestible formula of Citroxin. In independent laboratory testing Citroxin O2 was 100% successful in eradicating a strain of H95N avian influenza virus. The product is currently undergoing clinical testing to determine its efficacy in reducing the severity and duration of the effects of the influenza virus. Citroxin showed a 100% kill rate for the “big six” bacterial health threats as follows: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza and Black Mold.

Occusyn was developed as a treatment for Lyme disease, which costs society approximately $1 billion in direct and indirect costs per year. The product is currently undergoing clinical trials with encouraging initial results. Occusyn is a 100% food grade formulation.

OraPhyte has been tested and shown to be effective at eradicating nematodes, a phyla that includes more than 15,000 parasitic species. Nematode damage to food crops has been estimated at $100 billion. Three major universities with outstanding agricultural departments are currently conducting crop-specific research to determine its efficacy in controlling root rot and numerous other pathogenic conditions by eradicating plant nematodes.

PurEffect is an anti-acne skin care treatment system designed to address the needs of the 17 million Americans suffering from acne. Results of a recent clinical study conducted by an FDA-certified research facility reported that 94% of program participants preferred the results of the product’s 4-step treatment program when compared to traditional 3-step treatment programs.

Trimycin is currently undergoing testing for its efficacy in the eradication of the Tuberculosis organism (Mycobacterium Tuberculosis). Testing is being conducted by the National Center for Genetic Engineering and Biotechnology (BIOTEC), a branch of the National Science and Technology Department Agency, located in Bangkok, Thailand.

Initial results have been positive.